<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00870051</url>
  </required_header>
  <id_info>
    <org_study_id>P#888</org_study_id>
    <nct_id>NCT00870051</nct_id>
  </id_info>
  <brief_title>Endurant Stent Graft Natural Selection Global Postmarket Registry</brief_title>
  <acronym>ENGAGE</acronym>
  <official_title>Endurant Stent Graft Natural Selection Global Postmarket Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of ENGAGE is to prospectively collect global 'real world' data on the Endurant
      Stent Graft System from AAA subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Endurant Stent Graft Natural Selection Global Post-market Registry, ENGAGE is initiated
      to expand the clinical knowledge base by including 'real world' subjects, applying a minimal
      amount of subject selection criteria. This subject group may better represent the subject
      profile treated in actual clinical practice without selecting sub-groups of particular
      low/high risk or excluding certain diseases. ENGAGE aims at following and documenting the
      subject selections, diagnostic tools used and treatment interventions chosen by the vascular
      surgeon or interventional radiologist. ENGAGE will not impose CIP required study procedures
      affecting clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Success</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Migration</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Patency</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Endoleaks</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary procedures to correct Type I and III endoleaks</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary endovascular procedure</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Device Effects</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical Observations</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm-related mortality</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAE</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life Scores</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Stenosis</measure>
    <time_frame>10 years</time_frame>
    <description>Stent Graft stenosis is considered a reduction in the diameter of the stent graft lumen as compared to the reference. SG stenosis will be assessed by imaging as CT with contrast, Ultrasound, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AAA Diameter Increase</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>AAA patients</arm_group_label>
    <description>Subjects diagnosed with an AAA who are considered candidates for endovascular repair with Endurant Stent Graft, and who meet the inclusion/exclusion criteria are intended to participate in this registry</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endurant Stent Graft</intervention_name>
    <description>Endurant Stent Graft implantation</description>
    <arm_group_label>AAA patients</arm_group_label>
    <other_name>EVAR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects diagnosed with an AAA who are considered candidates for endovascular
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years or minimum age as required by local regulations

          -  Indication for elective surgical repair of AAA with an endovascular stent graft in
             accordance with the applicable guidelines on endovascular interventions and the
             Instructions for Use of the Endurant Stent Graft System

          -  Signed consent form (&quot;Patient informed consent Form&quot; or &quot;Patient Data Release
             Authorization Form&quot;). The subject or legal representative has been informed of the
             nature of the trial and has consented to participate and authorized the collection and
             release of his medical information

          -  Intention to electively implant the ENDURANT Stent Graft System

          -  Ability and willingness to comply with the CIP.

        Exclusion Criteria:

          -  High probability of non-adherence to physician's follow-up requirements

          -  Current participation in a concurrent trial which may confound study results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vicente Riambau, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Furuzan Numan, prof</last_name>
    <role>Study Director</role>
    <affiliation>Memorial Hospital Istanbul</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert A. Fitridge, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>The Queen Elizabeth Hospital, Woodville, South Adelaide, Australia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yehuda Wolf, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Tel Aviv Sourasky Medical Center, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dittmar Böckler, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Universtiy of Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Hayes, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Addenbrookes Hospital, Cambridge, Great Britain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Queen Elizabeth Hospital</name>
      <address>
        <city>Adelaide</city>
        <zip>SA 5011</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <results_reference>
    <citation>Böckler D, Fitridge R, Wolf Y, Hayes P, Silveira PG, Numan F, Riambau V; ENGAGE Investigators. Rationale and design of the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE): interim analysis at 30 days of the first 180 patients enrolled. J Cardiovasc Surg (Torino). 2010 Aug;51(4):481-91.</citation>
    <PMID>20671632</PMID>
  </results_reference>
  <results_reference>
    <citation>Stokmans RA, Teijink JA, Forbes TL, Böckler D, Peeters PJ, Riambau V, Hayes PD, van Sambeek MR. Early results from the ENGAGE registry: real-world performance of the Endurant Stent Graft for endovascular AAA repair in 1262 patients. Eur J Vasc Endovasc Surg. 2012 Oct;44(4):369-75. doi: 10.1016/j.ejvs.2012.07.005. Epub 2012 Jul 24.</citation>
    <PMID>22835762</PMID>
  </results_reference>
  <results_reference>
    <citation>Stokmans RA, Teijink JA, Cuypers PW, Riambau V, van Sambeek MR. No differences in perioperative outcome between symptomatic and asymptomatic AAAs after EVAR: an analysis from the ENGAGE Registry. Eur J Vasc Endovasc Surg. 2012 Jun;43(6):667-73. doi: 10.1016/j.ejvs.2012.02.034. Epub 2012 Mar 21.</citation>
    <PMID>22440235</PMID>
  </results_reference>
  <results_reference>
    <citation>Dubois L, Novick TV, Harris JR, Derose G, Forbes TL. Outcomes after endovascular abdominal aortic aneurysm repair are equivalent between genders despite anatomic differences in women. J Vasc Surg. 2013 Feb;57(2):382-389.e1. doi: 10.1016/j.jvs.2012.09.075. Epub 2012 Dec 21.</citation>
    <PMID>23266281</PMID>
  </results_reference>
  <results_reference>
    <citation>Pol RA, Zeebregts CJ, van Sterkenburg SM, Reijnen MM; ENGAGE Investigators. Thirty-day outcome and quality of life after endovascular abdominal aortic aneurysm repair in octogenarians based on the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE). J Vasc Surg. 2012 Jul;56(1):27-35. doi: 10.1016/j.jvs.2011.12.080. Epub 2012 Mar 28.</citation>
    <PMID>22459746</PMID>
  </results_reference>
  <results_reference>
    <citation>Tang T, Sadat U, Walsh S, Hayes PD; ENGAGE Investigators. Comparison of the endurant bifurcated endograft vs. aortouni-iliac stent-grafting in patients with abdominal aortic aneurysms: experience from the ENGAGE registry. J Endovasc Ther. 2013 Apr;20(2):172-81. doi: 10.1583/1545-1550-20.2.172.</citation>
    <PMID>23581758</PMID>
  </results_reference>
  <results_reference>
    <citation>Pol RA, Zeebregts CJ, van Sterkenburg SM, Ferreira LM, Goktay Y, Reijnen MM; Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE) Investigators. Outcome and quality of life after endovascular abdominal aortic aneurysm repair in octogenarians. J Vasc Surg. 2014 Aug;60(2):308-17. doi: 10.1016/j.jvs.2014.02.009. Epub 2014 Mar 20.</citation>
    <PMID>24657065</PMID>
  </results_reference>
  <results_reference>
    <citation>Kiguchi MM, Forbes TL, Teijink JA, Pliagas GA, Ellozy SH, Böckler D, Makaroun MS. Clinical application and early outcomes of the aortouni-iliac configuration for endovascular aneurysm repair. J Vasc Surg. 2014 Dec;60(6):1452-9. doi: 10.1016/j.jvs.2014.08.063. Epub 2014 Oct 3. Erratum in: J Vasc Surg. 2015 Jan;61(1):285. Boeckler, Dittmar [Corrected to Böckler, Dittmar].</citation>
    <PMID>25282698</PMID>
  </results_reference>
  <results_reference>
    <citation>Faure EM, Becquemin JP, Cochennec F; ENGAGE collaborators. Predictive factors for limb occlusions after endovascular aneurysm repair. J Vasc Surg. 2015 May;61(5):1138-45.e2. doi: 10.1016/j.jvs.2014.11.084. Epub 2015 Feb 2. Review.</citation>
    <PMID>25656594</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2009</study_first_submitted>
  <study_first_submitted_qc>March 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2009</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endurant</keyword>
  <keyword>Stent Graft</keyword>
  <keyword>Abdominal Aortic Aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

